Literature DB >> 8118028

Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin).

E U Saelman1, H K Nieuwenhuis, K M Hese, P G de Groot, H F Heijnen, E H Sage, S Williams, L McKeown, H R Gralnick, J J Sixma.   

Abstract

Platelet adhesion to fibrillar collagens (types I, II, III, and V) and nonfibrillar collagens (types IV, VI, VII, and VIII) was investigated in the presence of physiologic concentrations of divalent cations under conditions of stasis and flow. Under static conditions, platelet adhesion was observed to collagen types I through VII but not to type VIII. Under flow conditions, platelet adhesion to collagen types I, II, III, and IV was almost independent of shear rates above 300/s. Collagen type V was nonadhesive. Platelet adhesion to collagen type VI was shear rate-dependent and optimal at a rate of 300/s. Collagen types VII and VIII showed minor reactivity and supported platelet adhesion only between shear rates 100 to 1,000/s. Monoclonal antibody (MoAb) 176D7, directed against platelet membrane glycoprotein Ia (GPIa; very late antigen [VLA]-alpha 2 subunit), completely inhibited platelet adhesion to all collagens tested, under conditions of both stasis and flow. Platelet adhesion to collagen type III at shear rate 1,600/s was only inhibited for 85%. The concentration of antibody required for complete inhibition of platelet adhesion was dependent on the shear rate and the reactivity of the collagen. An MoAb directed against GPIIa (VLA-beta subunit) partially inhibited platelet adhesion to collagen. These results show that GPIa-IIa is a major and universal platelet receptor for eight unique types of collagen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8118028

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.

Authors:  Gavin E Jarvis; Ben T Atkinson; Daniel C Snell; Steve P Watson
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

2.  Crucial role for the VWF A1 domain in binding to type IV collagen.

Authors:  Veronica H Flood; Abraham C Schlauderaff; Sandra L Haberichter; Tricia L Slobodianuk; Paula M Jacobi; Daniel B Bellissimo; Pamela A Christopherson; Kenneth D Friedman; Joan Cox Gill; Raymond G Hoffmann; Robert R Montgomery
Journal:  Blood       Date:  2015-02-06       Impact factor: 22.113

3.  Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood.

Authors:  Nicholas Pugh; Anna M C Simpson; Peter A Smethurst; Philip G de Groot; Nicolas Raynal; Richard W Farndale
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

Review 4.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

5.  Morphological relationships of von Willebrand factor, type VI collagen, and fibrillin in human vascular subendothelium.

Authors:  X X Wu; R E Gordon; R W Glanville; H J Kuo; R R Uson; J H Rand
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

6.  Click-coated, heparinized, decellularized vascular grafts.

Authors:  Sashka Dimitrievska; Chao Cai; Amanda Weyers; Jenna L Balestrini; Tylee Lin; Sumati Sundaram; Go Hatachi; David A Spiegel; Themis R Kyriakides; Jianjun Miao; Guoyun Li; Laura E Niklason; Robert J Linhardt
Journal:  Acta Biomater       Date:  2014-11-20       Impact factor: 8.947

7.  Defective collagen binding and increased bleeding in a murine model of von Willebrand disease affecting collagen IV binding.

Authors:  T L Slobodianuk; C Kochelek; J Foeckler; S Kalloway; H Weiler; V H Flood
Journal:  J Thromb Haemost       Date:  2018-12-18       Impact factor: 5.824

8.  The role of fibrinogen spacing and patch size on platelet adhesion under flow.

Authors:  Aurore B Van de Walle; Jeffrey Fontenot; Travis G Spain; Daniel B Brunski; Ernest S Sanchez; Joel C Keay; Mark E Curtis; Matthew B Johnson; Trevor A Snyder; David W Schmidtke
Journal:  Acta Biomater       Date:  2012-07-20       Impact factor: 8.947

Review 9.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

10.  Association of the platelet membrane glycoprotein I a C807T gene polymorphism with aspirin resistance.

Authors:  Guanhua Su; Zhaohui Wang; Yanping Ding
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.